The Role of the Social Network in Fatal Opioid Overdose Prevention: The Former Opioid User’s Perspective

AuthorQuri Wygonik,Kasey Tucker-Gail,Tavis Glassman
Published date01 July 2021
Date01 July 2021
DOI10.1177/00220426211006365
Subject MatterArticles
https://doi.org/10.1177/00220426211006365
Journal of Drug Issues
2021, Vol. 51(3) 576 –589
© The Author(s) 2021
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/00220426211006365
journals.sagepub.com/home/jod
Article
The Role of the Social Network
in Fatal Opioid Overdose
Prevention: The Former
Opioid User’s Perspective
Quri Wygonik1, Tavis Glassman1,
and Kasey Tucker-Gail1
Abstract
Naloxone hydrochloride (naloxone) is an effective fatal opioid overdose prevention strategy.
The study findings describe former opioid users’ phenomenological perspectives regarding their
social network, settings of use, and the benefits and barriers to naloxone. Participants (N = 25)
with at least 6 months of recovery time (M = 30, SD = 14.40) were interviewed individually
for an average of 21 (SD = 5.13) min. The sample was predominately male, Caucasian, and non-
Hispanic with an average age of 37 (SD = 7.22) years. Interview transcripts were analyzed using
systematic thematic analysis. During their period of opioid use, most participants differentiated
the members of their social network as other people who use opioids (PWUO) and nonusers.
The participants described several opportunities for members of their social network to use
naloxone. They discussed barriers to naloxone use specific to PWUO within their social
network such as apathy toward overdose. Future interventions should be tailored to address
naloxone use barriers specific to PWUO and nonusers.
Keywords
opioids, overdose, naloxone, social networks, former opioid users
Introduction
Fatal opioid overdoses are a public health crisis gaining much attention. While in 2020 the
Centers for Disease Control and Prevention (CDC) reported a decline in overdose deaths
related to prescription opioids and heroin in the United States, fatalities related to synthetic
opioids such as fentanyl are on the rise (Wilson et al., 2020). From 2017 to 2018, an increase
in fentanyl-related deaths was experienced among persons aged 25 years or older, non- Hispanic
Whites, non-Hispanic Blacks, Hispanics, and non-Hispanic Asian/Pacific Islanders (Wilson
et al., 2020). Naloxone hydrochloride (naloxone) is an effective antidote to an opioid overdose
and is accessible to nonmedical laypersons like members of the social network of people who
use opioids (PWUO) (Campo-Flores & Elinson, 2014; Corso & Townley, 2016; Goldberg
et al., 2017; van Dorp et al., 2007).
1The University of Toledo, OH, USA
Corresponding Author:
Quri Wygonik, The University of Toledo, 2801 W. Bancroft Street, Toledo, OH 43606, USA.
Email: quri.danielswitt@rockets.utoledo.edu
1006365JODXXX10.1177/00220426211006365Journal of Drug IssuesWygonik et al.
research-article2021

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT